Rehabilitation With HHFNC in COPD in Nocturnal NIV
Chronic Obstructive Pulmonary Disease
About this trial
This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease focused on measuring COPD, HHFNC, Chronic Obstructive Pulmonary Disease, Humidified High Flow Nasal Cannula, Non Invasive Ventilation
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Chronic Obstructive Pulmonary Disease (post-bronchodilator Forced Expiratory Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) <0.7) ;
- Nocturnal Non Invasive Ventilation (NIV) prescription according to ATS/ERS guidelines with or without long-term oxygen therapy;
- Clinical stability (no exacerbation and no changing in respiratory drugs in the last 7 days);
Exclusion Criteria:
- Orthopedic or neurological pathologies that limit physical performance;
- Cognitive impairment (Mini-Mental State Examination <24);
- Advanced heart disease, pulmonary fibrosis, participation in other clinical studies in the six months preceding the start of the study.
Sites / Locations
- IRCCS Santa Maria Nascente, Fondazione Don Carlo GnocchiRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Rehabilitation with HHFNC
Control Group rehabilitation without HHFNC
15 Chronic Obstructive Pulmonary Disease patients in nocturnal Non Invasive Ventilation (NIV) who will perform rehabilitation, with / without Oxygen Therapy according to prescription, and with Humified High Flow Nasal Cannula (HHFNC). The Rehabilitation program consists in 20 session of 40 minutes, thrice a week for three times with a washout period of 3 months.
15 Chronic Obstructive Pulmonary Disease patients in nocturnal Non Invasive Ventilation (NIV) who will perform rehabilitation, with / without Oxygen Therapy according to prescription, without Humified High Flow Nasal Cannula (HHFNC). The Rehabilitation program consists in 20 session of 40 minutes, thrice a week for three times with a washout period of 3 months.